An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-80
SponsorUniversity of Illinois at Chicago

About this trial

RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.

Eligibility criteria

Qualifiers

Self-identifies as Black or African American

Age ≥35 to ≤80 years old

CKD Stage 1-4

Self-reported 6 or more hours/day of sedentary time

Disqualifiers

Being unable to walk 1 block

Being unable to stand from a seated position without assistance

Using a wheelchair, walker, or cane for all of their ambulation

Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension

Trial design

Treatments tested in this trial

  • RESET-CKD
  • Attention Control

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Illinois at Chicago

Lead sponsor

National Institute of Nursing Research (NINR)

Collaborator